banner
bhernando.bsky.social
Barbara Hernando
@bhernando.bsky.social
130 followers 310 following 5 posts
Postdoctoral Junior Leader at CNIO funded by LaCaixa | Cancer genomics, evolution & early detection | Heptathlete forever
Posts Media Videos Starter Packs
bhernando.bsky.social
Barbara Hernando @bhernando.bsky.social · 9d
Exciting 3 months ahead at the #AitkenLab @yaleschoolofmed.bsky.social! 🤩

Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨
s-j-aitken.bsky.social
Sarah Aitken @s-j-aitken.bsky.social · 9d
🥳 Today we welcome Dr Bárbara Hernando @bhernando.bsky.social to the #AitkenLab @yaleschoolofmed.bsky.social

Bárbara joins us from #CNIO as part of her @caixaresearch.bsky.social Postdoctoral Junior Leader Fellowship

@yalepathology.bsky.social @yalecancer.bsky.social @cniostopcancer.bsky.social
1 5
Reposted by Barbara Hernando
cniostopcancer.bsky.social
cniostopcancer.bsky.social @cniostopcancer.bsky.social · Jun 23
#CNIOStopCancer develop test that predicts which patients will not respond to cancer chemotherapy. They have identified biomarkers which, in clinical practice, would allow for more effective treatments and the avoidance of side effects.

http://bit.ly/465QqnR
1 1 1
Reposted by Barbara Hernando
cniostopcancer.bsky.social
cniostopcancer.bsky.social @cniostopcancer.bsky.social · Jun 23
Un estudio del #CNIOStopCancer descubre biomarcadores que predicen qué pacientes no responderán a la quimioterapia contra el cáncer. Podrían servir para descartar tratamientos que no van a funcionar, pero provocan efectos secundarios y son caros. 

http://bit.ly/4lj1QJn
1 1 1
Reposted by Barbara Hernando
gmaci.bsky.social
Geoff Macintyre @gmaci.bsky.social · Jun 23
🚨Chemo treatment upgrade!🚨

Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇
www.nature.com
1 9 16
bhernando.bsky.social
Barbara Hernando @bhernando.bsky.social · Jun 10
💥New preprint from the @gmaci.bsky.social lab!

Thrilled to share this major team effort, with #Angel as co-first author, now live on bioRxiv!

Check out our threat to learn more about our work👇
gmaci.bsky.social
Geoff Macintyre @gmaci.bsky.social · Jun 10
If tumour genome evolution is deterministic, can we forecast genomic changes? Yes we can! At least for oncogene amps and tumour suppressor dels. @bhernando.bsky.social Angel Fernandez-Sanroman present our method for forecasting driver gene copy number change. Preprint: bit.ly/4kxF14y ⬇️1/
Forecasting oncogene amplification and tumour suppressor deletion
Oncogene amplification and tumour suppressor deletion can drive tumour initiation, progression and treatment resistance. Detection at diagnosis often signals poor prognosis, but it can also enable opp...
bit.ly
1
bhernando.bsky.social
Barbara Hernando @bhernando.bsky.social · May 14
Flying back from Bologna after the Pan Prostate Cancer Group #PPCG meeting. 3 days of fruitful discussions with lovely colleagues at the best venue I have ever been 🤩
2
bhernando.bsky.social
Barbara Hernando @bhernando.bsky.social · Apr 27
Day 1 at #AACR2025 from my side! Meanwhile, at the #EMBO workshop on Chromosome Segregation and Aneuploidy, Maria Escobar will be presenting our project on ongoing CIN in KRAS mutant pancreatic organoids! A must meeting for the #CIN community meetings.embo.org/event/25-ane...
Chromosome Segregation and Aneuploidy
Aneuploidy is a hallmark of cancer and developmental disorders such as Down syndrome. Understanding how cells accomplish faithful chromosome segregation and how chromosomal instability (CIN) impacts …
meetings.embo.org
1 3
bhernando.bsky.social
Barbara Hernando @bhernando.bsky.social · Apr 26
Ready for #AACR25! Excited for five full days of talks, posters and educational sessions in cancer research, and also for catching up with colleagues and friends 🤩
8